title: Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
abstract: Innate immune responses elicited upon virus exposure are crucial for the effective eradication of viruses, the onset of adaptive immune responses and for establishing proper immune memory. Respiratory syncytial virus (RSV) is responsible for a high disease burden in neonates and immune compromised individuals, causing severe lower respiratory tract infections. During primary infections exuberant innate immune responses may contribute to disease severity. Furthermore, immune memory is often insufficient to protect during RSV re-exposure, which results in frequent symptomatic reinfections. Therefore, identifying the cell types and pattern recognition receptors (PRRs) involved in RSV-specific innate immune responses is necessary to understand incomplete immunity against RSV. We investigated the innate cellular response triggered upon infection of epithelial cells and peripheral blood mononuclear cells. We show that CD14(+) myeloid cells and epithelial cells are the major source of IL-8 and inflammatory cytokines, IL-6 and TNF-α, when exposed to live RSV Three routes of RSV-induced IFN-α production can be distinguished that depend on the cross-talk of different cell types and the presence or absence of virus specific antibodies, whereby pDC are the ultimate source of IFN-α. RSV-specific antibodies facilitate direct TLR7 access into endosomal compartments, while in the absence of antibodies, infection of monocytes or epithelial cells is necessary to provide an early source of type I interferons, required to engage the IFN-α,β receptor (IFNAR)-mediated pathway of IFN-α production by pDC. However, at high pDC density infection with RSV causes IFN-α production without the need for a second party cell. Our study shows that cellular context and immune status are factors affecting innate immune responses to RSV. These issues should therefore be addressed during the process of vaccine development and other interventions for RSV disease.
authors.affiliation: Department of Pediatrics, The Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands ; Department of Immunology, Danone Research - Centre for Specialised Nutrition, Wageningen, The Netherlands.
authors.forename: Marcel A
authors.initials: MA
authors.lastname: Schijf
authors.forename: Michael V
authors.initials: MV
authors.lastname: Lukens
authors.forename: Debby
authors.initials: D
authors.lastname: Kruijsen
authors.forename: Nathalie O P
authors.initials: NO
authors.lastname: van Uden
authors.forename: Johan
authors.initials: J
authors.lastname: Garssen
authors.forename: Frank E J
authors.initials: FE
authors.lastname: Coenjaerts
authors.forename: Belinda
authors.initials: B
authors.lastname: Van't Land
authors.forename: Grada M
authors.initials: GM
authors.lastname: van Bleek
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology*; D000918:Antibody Specificity / Q000276:immunology; D002450:Cell Communication; D018929:Cell Culture Techniques; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators; D007370:Interferon Type I / Q000096:biosynthesis*; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000378:metabolism / Q000821:virology; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism / Q000821:virology; D017471:Receptors, Interferon / Q000378:metabolism; D020545:Respiratory Mucosa / Q000276:immunology* / Q000378:metabolism*; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000378:metabolism; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology*; D015398:Signal Transduction; D051199:Toll-Like Receptor 7 / Q000378:metabolism; D053585:Virus Attachment
chemical_list: D000914:Antibodies, Viral; D016207:Cytokines; D018836:Inflammation Mediators; D007370:Interferon Type I; D018950:Lipopolysaccharide Receptors; D017471:Receptors, Interferon; D051199:Toll-Like Receptor 7